Talal Alkayali, MBBS

Talal Alkayali practices at Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System.

Talal Alkayali's NPI, 1700310851, was assigned on April 15, 2017. Talal Alkayali graduated from Jordan University of Science and Technology FOM in 2014. Talal Alkayali holds Florida license ME145677.

Talal Alkayali's primary practice is Sarasota Memorial Hospital - Sarasota Campus, at 1700 S Tamiami Trl, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 917-9000.

Talal Alkayali's primary practice is Sarasota Memorial Hospital - Sarasota Campus in Sarasota, Florida, part of Sarasota Memorial Health Care System. Talal Alkayali is also affiliated with Sarasota Memorial Hospital-Venice. The medical group on file is First Physicians Group of Sarasota. Dmand AI also links Talal Alkayali to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Talal Alkayali practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Talal Alkayali's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Talal Alkayali is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Talal Alkayali's licenses on file in 3 states: Florida, Maryland and California.

Dmand AI lists acute skin infection, ankle or foot injury, chronic skin ulcer, intestinal diverticulosis and UTI among the conditions Talal Alkayali treats.

CMS data shows 128,749 Medicare services from Talal Alkayali across 25 procedure codes in 2024, for 1,826 Medicare patients. Medicare paid $510,225 for them.

CMS counts 1,826 Medicare patients who saw Talal Alkayali in 2024. The largest group is 75 to 84, with 731 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Talal Alkayali's median patient age at 75, with 45% women.

In 2024, Talal Alkayali wrote 542 Medicare Part D claims for 159 patients. 80% of them were for generic drugs. CMS names the drug for 363 of them, across 15 drugs with 11 or more claims each, at $212,223 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Talal Alkayali for performance year 2024, reported as part of a group. Talal Alkayali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Talal Alkayali as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Talal Alkayali, published from 2020 to 2024. 2020 was the busiest year, with 3. Talal Alkayali has published most often in Cureus. Talal Alkayali's most frequent co-authors are Natalia Lattanzio, MD, Qassem Khaled Abdelal, MD and Anthony David Amoroso, MD.

CMS Open Payments shows 13 general payments to Talal Alkayali from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 98% of the total. ViiV Healthcare Company paid the most, $369.

Talal Alkayali graduated from Jordan University of Science and Technology FOM in 2014.

Talal Alkayali is in network with 16 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.